DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Aldurazyme (Laronidase) - Published Studies

 
 



Aldurazyme Related Published Studies

Well-designed clinical trials related to Aldurazyme (Laronidase)

A dose-optimization trial of laronidase (Aldurazyme) in patients with mucopolysaccharidosis I. [2009.01]

Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I. [2009.01]

Laronidase for treating mucopolysaccharidosis type I. [2007.09.30]

Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase). [2004.05]

Well-designed clinical trials possibly related to Aldurazyme (Laronidase)

Ocular changes in patients with mucopolysaccharidosis I receiving enzyme replacement therapy: a 4-year experience. [2007.10]

Other research related to Aldurazyme (Laronidase)

Laronidase replacement therapy improves myocardial function in mucopolysaccharidosis I. [2011.07]

Laronidase for cardiopulmonary disease in Hurler syndrome 12 years after bone marrow transplantation. [2010.11]

Cognitive and neuroradiological improvement in three patients with attenuated MPS I treated by laronidase. [2010.05]

Efficacy of recombinant human alpha-L-iduronidase (laronidase) on restricted range of motion of upper extremities in mucopolysaccharidosis type I patients. [2010.04]

Anthropometric data of 14 patients with mucopolysaccharidosis I: retrospective analysis and efficacy of recombinant human alpha-L-iduronidase (laronidase). [2010.01]

[The development of cognitive functions in children with Hurler phenotype mucopolysaccharidosis type I on enzyme replacement therapy with laronidase]. [2010]

Use of enzyme replacement therapy (Laronidase) before hematopoietic stem cell transplantation for mucopolysaccharidosis I: experience in 18 patients. [2009.01]

Laronidase (Aldurazyme): enzyme replacement therapy for mucopolysaccharidosis type I. [2008.07]

Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase). [2007.07]

A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years. [2007.02]

Outcome after three years of laronidase enzyme replacement therapy in a patient with Hurler syndrome. [2006.12]

A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years. [2006.09.28]

Impact of 144 weeks of laronidase therapy on body functions, endurance and general well-being in a Hurler-Scheie patient. [2006.08]

Effect of discontinuing of laronidase in a patient with mucopolysaccharidosis type I. [2006.02]

Changes in hair morphology of mucopolysaccharidosis I patients treated with recombinant human alpha-L-iduronidase (laronidase, Aldurazyme). [2005.12.15]

The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I. [2005.03]

Laronidase treatment of mucopolysaccharidosis I. [2005]

Mucopolysaccharidosis I under enzyme replacement therapy with laronidase--a mortality case with autopsy report. [2005]

Other possibly related research studies

[Enzyme replacement therapies for lysosomal storage disorders.] [2005.12]

Enzyme replacement therapy in mucopolysaccharidosis type I. [2005.03]

Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome. [2005.02]

Enzyme replacement therapy in two patients with an advanced severe (Hurler) phenotype of mucopolysaccharidosis I. [2007.07]

Successful treatment of severe heart failure in an infant with Hurler syndrome. [2007.10]

Enzyme replacement therapy in 12 patients with MPS I-H/S with homozygous p.Leu490Pro mutation. [2007.10]

[Hurler syndrome. Early diagnosis and successful enzyme replacement therapy: a new therapeutic approach. Case report] [2008.01]

Intrathecal enzyme replacement therapy in a patient with mucopolysaccharidosis type I and symptomatic spinal cord compression. [2008.10.01]

Enzyme-replacement therapy in a 5-month-old boy with attenuated presymptomatic MPS I: 5-year follow-up. [2010.01]

[Enzyme replacement therapy of lysosomal storage diseases]. [2010.12]

Ethical issues related to the access to orphan drugs in Brazil: the case of mucopolysaccharidosis type I. [2011.04]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014